0
0

Safe Step Act

3/8/2024, 8:15 AM

Summary of Bill HR 2630

The Safe Step Act, also known as Bill 118 hr 2630, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to address the issue of step therapy, which is a practice used by insurance companies to require patients to try and fail on lower-cost medications before they can receive coverage for the medication prescribed by their healthcare provider.

The Safe Step Act aims to protect patients by establishing guidelines for step therapy protocols. It requires insurance companies to implement a clear and transparent process for requesting exceptions to step therapy requirements. This process must be based on clinical guidelines and take into account the individual needs of the patient.

Additionally, the bill requires insurance companies to respond to these exception requests in a timely manner, ensuring that patients are not left waiting for necessary medications. It also allows for expedited review in cases where a delay in treatment could cause harm to the patient. Overall, the Safe Step Act seeks to prioritize the health and well-being of patients by ensuring that they have timely access to the medications prescribed by their healthcare providers. This legislation has garnered bipartisan support and is seen as a positive step towards improving patient care in the United States.

Congressional Summary of HR 2630

Safe Step Act

This bill requires a group health plan to establish an exception to medication step-therapy protocol in specified cases. A medication step-therapy protocol establishes a specific sequence in which prescription drugs are covered by a group health plan or a health insurance issuer. 

A request for such an exception to the protocol must be granted if (1) an otherwise required treatment has been ineffective, (2) such treatment is expected to be ineffective and delaying effective treatment would lead to irreversible consequences, (3) such treatment will cause or is likely to cause an adverse reaction to the individual, (4) such treatment is expected to prevent the individual from performing daily activities or occupational responsibilities, (5) the individual is stable based on the prescription drugs already selected, or (6) there are other circumstances as determined by the Employee Benefits Security Administration.

The bill requires a group health plan to implement and make readily available a clear process for an individual to request an exception to the protocol, including required information and criteria for granting an exception. The bill further specifies timelines under which plans must respond to such requests.

Current Status of Bill HR 2630

Bill HR 2630 is currently in the status of Bill Introduced since April 13, 2023. Bill HR 2630 was introduced during Congress 118 and was introduced to the House on April 13, 2023.  Bill HR 2630's most recent activity was Referred to the House Committee on Education and the Workforce. as of April 13, 2023

Bipartisan Support of Bill HR 2630

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
344
Democrat Cosponsors
214
Republican Cosponsors
130
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 2630

Primary Policy Focus

Health

Potential Impact Areas

- Drug therapy
- Employee benefits and pensions
- Health care costs and insurance
- Health care coverage and access
- Prescription drugs

Alternate Title(s) of Bill HR 2630

Safe Step Act
Safe Step Act
To amend the Employee Retirement Income Security Act of 1974 to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes.

Comments

Latest Bills

A resolution commending the American Chemical Society on the occasion of its 150th anniversary and recognizing its many years of service to the United States.
Bill SRES 702May 4, 2026
Commending the American Chemical Society on the occasion of its 150th anniversary and recognizing its many years of service to the United States.
Bill HRES 1157May 4, 2026
A resolution supporting the mission and goals of National Fentanyl Awareness Day in 2026, including increasing individual and public awareness of the impact of fake or counterfeit fentanyl pills on families and young people.
Bill SRES 704May 4, 2026
Supporting the mission and goals of National Fentanyl Awareness Day in 2026, including increasing individual and public awareness of the impact of fake or counterfeit fentanyl pills on families and young people.
Bill HRES 1234May 4, 2026
A resolution expressing support for the designation of the week of May 3, 2026, through May 9, 2026, as "National Small Business Week" to celebrate the contributions of small businesses and entrepreneurs in every community in the United States.
Bill SRES 703May 4, 2026
A resolution designating the week of April 20 through 26, 2026, as "National Dark Sky Week".
Bill SRES 701May 4, 2026
A resolution recognizing the significance of Community College Month in April as a celebration of more than 1,000 institutions throughout the United States supporting access to higher education, workforce training, and more broadly sustaining and advancing the economic prosperity of the United States.
Bill SRES 686May 4, 2026
A resolution designating the week of April 20 through April 24, 2026, as "National Home Visiting Week".
Bill SRES 692May 4, 2026
A bill to amend the FISA Amendments Act of 2008 to extend the authorities of title VII of the Foreign Intelligence Surveillance Act of 1978, and for other purposes.
Bill S 4465May 4, 2026
A resolution recognizing and supporting the goals and ideals of National Sexual Assault Awareness and Prevention Month.
Bill SRES 693May 4, 2026
Safe Step Act
Bill S 652March 12, 2024
Pharmacy Benefit Manager Reform Act
Bill S 1339December 15, 2023